Fibrobiologics IncNASDAQ:FBLG
- LAST PRICE2.6200
- TODAY'S CHANGE (%)0.0600 (2.3437%)
- Bid / Lots2.2700/ 3
- Ask / Lots3.0500/ 23
- Open / Previous Close2.5100 / 2.5600
- Day Range
- 52 Week Range
- Volume62,504
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FBLG |
|---|---|---|
| 09:32 ET | 1529 | 2.51 |
| 09:33 ET | 2100 | 2.57 |
| 09:48 ET | 125 | 2.6966 |
| 09:53 ET | 3174 | 2.61 |
| 09:55 ET | 18555 | 2.68 |
| 10:02 ET | 320 | 2.65 |
| 10:06 ET | 1100 | 2.59 |
| 10:13 ET | 100 | 2.58 |
| 10:29 ET | 1175 | 2.54 |
| 10:31 ET | 200 | 2.5044 |
| 10:45 ET | 206 | 2.53 |
| 10:51 ET | 100 | 2.56 |
| 10:54 ET | 100 | 2.58 |
| 11:02 ET | 100 | 2.6 |
| 11:16 ET | 521 | 2.59 |
| 11:21 ET | 100 | 2.59 |
| 11:27 ET | 1400 | 2.59 |
| 11:32 ET | 1100 | 2.555 |
| 11:38 ET | 2100 | 2.585 |
| 11:43 ET | 500 | 2.59 |
| 11:45 ET | 150 | 2.5601 |
| 11:59 ET | 600 | 2.54 |
| 12:03 ET | 924 | 2.55 |
| 12:21 ET | 500 | 2.58 |
| 12:24 ET | 300 | 2.555 |
| 12:28 ET | 100 | 2.5362 |
| 12:35 ET | 100 | 2.56 |
| 12:37 ET | 100 | 2.54 |
| 12:44 ET | 100 | 2.56 |
| 12:50 ET | 600 | 2.59 |
| 12:53 ET | 1208 | 2.61 |
| 12:57 ET | 508 | 2.6 |
| 01:00 ET | 8814 | 2.62 |
Nov 20, 2024
DJ FibroBiologics Is Maintained at Buy by D. Boral Capital, from 7:33AM ET on Wednesday Nov 20, 2024 by Dow Jones
7:33AM ET on Wednesday Nov 20, 2024 by Dow Jones
Nov 19, 2024
FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly, from 9:15AM ET on Tuesday Nov 19, 2024 by Dow Jones
9:15AM ET on Tuesday Nov 19, 2024 by Dow Jones
Nov 14, 2024
Nov 13, 2024
DJ FibroBiologics Is Maintained at Buy by D. Boral Capital, from 6:11PM ET on Wednesday Nov 13, 2024 by Dow Jones
6:11PM ET on Wednesday Nov 13, 2024 by Dow JonesDJ FibroBiologics Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:44AM ET on Wednesday Nov 13, 2024 by Dow Jones
7:44AM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fibrobiologics Inc | 88.7M | -3.0x | --- |
Quince Therapeutics Inc | 88.9M | -1.6x | --- |
Vigil Neuroscience Inc | 89.9M | -1.2x | --- |
Annovis Bio Inc | 90.2M | -1.8x | --- |
Adicet Bio Inc | 91.5M | -0.7x | --- |
CAMP4 Therapeutics Corp | 91.5M | -1.8x | --- |
Company Information
FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
Contact Information
- Headquarters
- 455 E. Medical Center Blvd, Suite 300HOUSTON, TX, United States 77598
- Phone
- 281-671-5150
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Founder
- Pete Oheeron
- Chief Financial Officer, Director
- Robert Hoffman
- Chief Scientific Officer
- Hamid Khoja
- Independent Director
- Richard Cilento
- Independent Director
- Stacy Coen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $88.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 34.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.89 |
Book Value | $0.04 |
P/E Ratio | -3.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
